| A2 | adenosine receptor |
| Ab | antibody |
| ACh | acetylcholine |
| ACTH | adrenocorticotropic hormone |
| AJA | ajulemic acid |
| APF | antiproliferative factor |
| ASC | apoptosis-associated speck-like protein |
| A7R5 | smooth muscle cell line |
| AYPGKF-NH2 | PAR4 agonist |
| BCP | beta-caryophyllene |
| BTX-A | botulinum toxin A |
| CAT | catalase |
| CB | cannabinoid receptor |
| CBX | carbenexolone |
| CD | cluster of differentiation |
| CGRP | calcitonin gene-related peptide |
| CRH | corticotropin-releasing hormone |
| CS | chondroitin sulfate |
| CYP | cyclophosphamide |
| DMSO | dimethyl sulfoxide |
| DRG | dorsal root ganglia |
| ECSWT | extracorporeal shock wave therapy |
| EGCG | epigallocatechin gallate |
| eNOS | endothelial nitric oxide synthase |
| EP | prostaglandin E2 receptor subtype |
| ERK | extracellular signal-regulated kinase |
| FcεRIα | high-affinity IgE receptor |
| FTLK | transcriptional factors FOXA1, TP63, MYCL, and KLF4 |
| GAG | glycosaminoglycan |
| GM-0111 | modified GAG |
| GSDMD | gasdermin D |
| GSH | glutathione |
| HA | hyaluronic acid |
| H-BLAK | primary human bladder cell line |
| h-ESC | human embryonic stem cells |
| HMGB1 | high mobility group box 1 |
| HO-1 | heme oxygenase-1 |
| H2O2 | hydrogen peroxide |
| HTB4, HRB2 | human urothelial cells |
| ICAM | intercellular adhesion molecule |
| IC/BPS | interstitial cystitis/bladder pain syndrome |
| ICI | intercontraction interval |
| IFN-γ | interferon gamma |
| IκBα | inhibitor of NF-κB |
| IL | interleukin |
| iNOS | inducible nitric oxide synthase |
| JAK | janus kinase |
| KC | keratinocytes-derived chemokine |
| LDH | lactate dehydrogenase |
| LL37 | antimicrobial peptide |
| LPS | lipopolysaccharide |
| MAPK | mitogen-activated protein kinase |
| MCP-1 | monocyte chemoattractant protein-1 |
| MDA | malondialdehyde |
| MIF | macrophage migration inhibitory factor |
| miR | microRNA |
| MMP9 | matrix metalloproteinase 9 |
| M-MSC | multipotent mesenchymal stem cells |
| MPO | myeloperoxidase |
| MSC | mesenchymal stem cells |
| NF-κB | nuclear factor kappa B |
| NGF | nerve growth factor |
| NK1R | neurokinin 1 receptor |
| NLRP3 | NLR family pyrin domain-containing 3 |
| NMDAR | N-methyl-d-aspartate receptor |
| NOX | NAPDH oxidase |
| NQO-1 | NADPH quinine oxidoreductase |
| NRK-52E | renal tubular epithelial cell line |
| NVC | non-voiding contraction |
| OVX | ovariectomized |
| P1, P2 | purinoceptors |
| P2X | purinergic receptors |
| p38 | mitogen-activated protein kinase |
| p65 | NF-κB subunit |
| p-AKT | protein kinase B, phosphorylated |
| PAR | proteinase-activated receptor |
| PGE2 | prostaglandin 2 |
| PMN | polymorphonuclear cells |
| p-mTOR | mechanistic target of rapamycin, phosphorylated |
| POMC | pro-opiomelanocortin |
| PPAR | peroxisome proliferator-activated receptor |
| PPS | pentosan polysulfate sodium |
| PS | protamine sulfate |
| PTX3 | pentraxin 3 |
| RANTES | chemokine ligand 5 |
| RhoA | Ras homolog gene family, member A |
| rhsTM | recombinant human soluble thrombomodulin |
| ROCK | Rho-associated protein kinase; R |
| OS | reactive oxygen species; |
| RT112 | 3D human bladder epithelium preparation |
| SAGE | semi-synthetic glycosaminoglycan ethers |
| SC | stem cells |
| SD rats | Sprague-Dawley rats |
| sGC | soluble guanylyl cyclase |
| MAPK | mitogen-activated protein kinase |
| MCP-1 | monocyte chemoattractant protein-1 |
| MDA | malondialdehyde |
| SMAD | proteins for signal transduction of the transforming growth factor beta superfamily |
| TRPV | transient receptor potential channel, vanilloid subgroup |
| UPK | uroplakin |
| VEGF | vascular endothelial growth factor |
| ZO-1 | tight junction protein 1 |